Skip to Main Content

Paper Details

Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program.
Target Oncol
9
2018
Author NameAffiliation
Jill M PulleyVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Rebecca N JeromeVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Gordon R BernardVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Robert R LavieriVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Nicole M ZaleskiVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Jana K Shirey-RiceVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Ingrid A MayerVanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Kenneth J HolroydVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Kenneth J HolroydCenter for Technology Transfer and Commercialization, Vanderbilt University
  • 1 - 9

Datasets

Release 1.2